RP-HPLC Method Development and Validation for the Quantitative Estimation of Mirabegron in Extended-Release Tablets
Journal: Journal of Medicinal and Chemical Sciences (Vol.1, No. 2)Publication Date: 2018-10-01
Authors : Ali Ramazani; Mehdi Rezaei;
Page : 36-40
Keywords : Mirabegronو Validationو RP-HPLCو Method Development;
Abstract
In this study, we describe and validate a rapid and sensitive method for constitution of Mirabegron in the Extended-Release tablets by RP-HPLC. The assay method by HPLC was found to be linear in the concentration range of 10 to 100 µg/mL. Successful separation was achieved by isocratic elution on a Restek C18 column (250 mm × 4.6 mm, 5μm). The mobile phase was composed of buffer pH: 7.0 potassium dihydrogen phosphate and acetonitrile (60:40 v/v) at the flow rate of 1 mL/min using UV detection at 249 nm, column oven temperature 45ºC and injection volume 10 ????L. The analytical results were validated by recovery studies. The percentage recovery method was found to be 99.00-101.17%. The LOD and LOQ were found to 0.015 μg/mL and 0.049 μg/mL. All the parameters of validation were in the acceptable range. This developed method was successfully applied for estimate the amount of Mirabegron in the tablets.
Other Latest Articles
- Efficient and Alternative Characterization of transition aluminas (η, γ, ϴ, δ-Al2O3) Derived from Aeroxide: Application of FT-IR and SEM
- A density functional theory study on the effect of size on the ionization potential of different carbon fullerenes
- Biosynthesis of Iron Oxide Nanoparticles by Cytoplasmic Extract of Bacteria Lactobacillus Fermentum
- K2CO3/CS2: A mild and effiecint system for the prapartion of trithiocarbonates
- Spatial and Temporal Variability in Climate Variables Trends in the Marathwada Region of Maharashtra, India
Last modified: 2019-03-21 04:42:36